Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

Market Cap	13.66B -18.6%
Revenue (ttm)	1.00B +45.7%
Net Income	98.39M
EPS	0.24
Shares Out	442.94M
PE Ratio	129.26
Forward PE	n/a
Dividend	0.06 (0.19%)
Ex-Dividend Date	May 14, 2026

Volume	12,449,662
Open	31.02
Previous Close	31.17
Day's Range	30.31 - 31.35
52-Week Range	23.41 - 44.99
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the pharmaceutical industry in China. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for peripheral T-cell lymphoma, breast cancer, and diffuse large B-cell lymphoma indications; Chiglitazar, a PPAR full agonist for diabetes treatment; Siglitazone for metabolism treatment area; and Cioronib, a novel molecular, which selectively inhibits tumor-related protein kinase targets. It is also involved in the development of CS23546, a small molecule PD-L1 inhibitor, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,002
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688321

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 14, 2026

Data Sources Report a data error